SCHEMBL7124382

SCHEMBL7124382

Cn1c2c(c3ccccc31)C(C(C)(C)C1=CC=CC1)c1ccccc1-2

nearest known ligand 0.33

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.33
WDR5 P61964 1/20 0.33
GPR3 P46089 1/20 0.32
MAOA P21397 1/20 0.31
MAPT P10636 1/20 0.30
ALOX15 P16050 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7128843 0.85 L3MBTL1 (0.34) MAPT
SCHEMBL7117735 0.82 WDR5 (0.31) NTRK1WDR5
SCHEMBL7127988 0.81 NTRK1 (0.40) NTRK1WDR5GPR3MAOAMAPT
SCHEMBL7129142 0.78 NTRK1 (0.38) NTRK1WDR5GPR3MAOAMAPT
SCHEMBL5175651 0.77 GPR3 (0.33) GPR3
SCHEMBL7129138 0.77 WDR5 (0.31) NTRK1WDR5MAOAMAPTALOX15
SCHEMBL7130927 0.76 HSD11B1 (0.30)
SCHEMBL27669454 0.76 GPR3 (0.32) GPR3
SCHEMBL7130923 0.75 HSD11B1 (0.31)
Hydrochloric Acid SCHEMBL6560403 0.75 GPR3 (0.32) GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030148877-A1 Metallocenes and catalysts for olefin-polymerisation BASELL TECHNOLOGY COMPANY BV (NL) 2003-08-07 US disclosed
EP-0952978-B1 METALLOCENES AND CATALYSTS FOR OLEFIN-POLYMERISATION BASELL POLYOLEFINE GMBH (DE) 2003-01-22 EP disclosed
US-6451724-B1 BIS(N-METHYL-5,10-DIHYDROINDENO(1,2-B)INDOL-10 -YL)TITANIUM DICHLORIDE BASELL TECHNOLOGY COMPANY BV (NL) 2002-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030148877-A1 Metallocenes and catalysts for olefin-polymerisation MT-CO1, CPNE4, MT-CO3 NTRK1 3468/4885WDR5 4206/4885GPR3 3696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.